Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis

Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis

Background and aimGiven the paucity of evidence-based treatment recommendations, the most appropriate first-line regimen for adult Burkitt lymphoma is currently undefined. We aimed to identify the optimal treatment regimen containing rituximab for adult Burkitt lymphoma patients.MethodsThe PubMed, E...

Full description

Bibliographic Details
Main Authors: Xiaoxuan Lu, Yu Liu, Ruyu Liu, Jiaxin Liu, Xiaojing Yan, Liren Qian
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
Burkitt lymphoma
meta-analysis
chemotherapy regimen
rituximab
single-arm
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1063689/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1063689/full

Similar Items